Skip to main content

Find a clinical trial

Find a clinical trial

Trial status
Trial Phase
Trial type
9 clinical trials grid list download
  • Title Organ Phase Statut Major inclusion criteria Contact
  • 1367.1 An open label, Phase Ia/Ib dose finding study with BI 894999 orally administered once a day in patients with advanced malignancies, with repeated administration in patients with clinical benefit Multiples phase 1 Open any line, RECIST 1.1 Ahmad Hussein Awada
  • AMC303-01 A safety, tolerability and pharmacokinetic dose escalation expansion, Phase I/Ib study of AMC303 as monotherapy in patients with advanced or metastatic, malignant solid tumour of epithelial origin Multiples phase 1/1b Closed any line, RECIST 1.1 Philippe Aftimos
  • EORTC 1658 Qualification of imaging methods to assess cancer drug induced interstitial lung disease (ImageILD) Poumon Closed any line / Lung metastasis Konstantinos Stathopoulos
  • IJB_2728 Improving emotion regulation for patients with metastatic cancer: A pilot study assessing the impact of a multi-component psychological group intervention Tumeurs solides Open Metastatic, any tumors
  • Intervention destinée aux parents L'enfant face au cancer d'un parent: une étude randomisée évaluant l'efficacité d'une intervention psychologique destinée à soutenir la parentalité Tumeurs solides Open Be a parent or close relative of a child between the ages of 3 and 18 confronted with parental cancer, any tumors
  • OX2016-203-01 An open-label, dose-escalation, phase I study to assess the safety, pharmacokinetics and pharmacodynamics of AsiDNA, a DNA repair inhibitor administered intravenously in patients with advanced solid tumors Multiples phase 1 Open Any line/RECIST v1.1/Eligible for platinium salt chemotherapy Nuria Kotecki
  • PM1183-B-005-14 A Multicenter Phase II Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors Multiples phase 2 Closed brca 1/2 Ahmad Hussein Awada
  • Sevrage Tabagique Impact of an emotion and craving regulation intervention on smoking cessation and maintenance among oncology patients : a randomized study Tumeurs solides Open Smoker of quit smoking within the last 6 months, any tumors
  • SYD985.004 A two-part phase I study with the antibody-drug conjugate SYD985 in combination with niraparib to evaluate safety, pharmacokinetics and efficacy in patients with HER2-expressing locally advanced or metastatic solid tumours Multiples phase 1 Open RECIST v1.1 Philippe Aftimos